Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study-Reference-Cited by-同舟云学术

Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study

Published:2021-11-30 Issue:2 Volume:11 Page:371-379
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Hwang Kihwan¹,Kim Junhyung¹^ORCID,Kang Seok‐Gu²,Jung Tae‐Young³,Kim Jeong Hoon⁴,Kim Se‐Hyuk⁵,Kang Shin‐Hyuk⁶,Hong Yong‐Kil⁷,Kim Tae Min⁸,Kim Yu Jung¹,Choi Byung Se¹,Chang Jong Hee²,Kim Chae‐Yong¹

Affiliation:

1. Department of Neurosurgery Internal Medicine Radiology Seoul National University Bundang Hospital Seoul National University College of Medicine Seongnam Republic of Korea

2. Department of Neurosurgery Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea

3. Department of Neurosurgery Chonnam National University Hwasun Hospital Chonnam National University College of Medicine Hwasun Republic of Korea

4. Department of Neurosurgery Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

5. Department of Neurosurgery Ajou University Hospital Ajou University School of Medicine Suwon Republic of Korea

6. Department of Neurosurgery Korea University Medical Center Korea University College of Medicine Seoul Republic of Korea

7. Department of Neurosurgery Seoul St. Mary’s Hospital The Catholic University of Korea College of Medicine Seoul Republic of Korea

8. Department of Internal Medicine Seoul National University Hospital Seoul National University College of Medicine Seoul Republic of Korea

Funder

Seoul National University Bundang Hospital

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4454

Reference30 articles.

1. Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

3. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea

4. Toward precision medicine in glioblastoma: the promise and the challenges

5. Repurposed Drugs in Treating Glioblastoma Multiforme: Clinical Trials Update

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade glioma;2024-04-12

2. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21

3. Apolipoprotein E3 functionalized lipid-drug conjugated nanoparticles of Levetiracetam for enhanced delivery to the brain: In-vitro cell line studies and in-vivo study;International Journal of Biological Macromolecules;2024-01

4. Optimizing the management of glioblastoma per neurosurgical approach and therapeutic interventions on patient outcomes: A systematic review and meta-analysis;Annals of Oncology Research and Therapy;2024-01

5. Unexpected Transient Glioblastoma Regression in a Patient Previously Treated with Bacillus Calmette–Guérin Therapy: A Case Report and Immunomodulatory Effects Hypothesis;Journal of Personalized Medicine;2023-11-28